An Open-Label Study to Assess Safety

Completed · Phase 1

Conditions studied: Plaque Psoriasis

In brief

An Open-Label study to assess safety

Key facts

Study ID

NCT03645499

Run by

Sun Pharmaceutical Industries, Inc.

People needed

88

Starts

2018-04-04

Expected to finish

2020-01-07

Last updated by the study team

2022-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or non-pregnant female aged ≥ 18 years with a clinical diagnosis of plaque psoriasis.
• Definite clinical diagnosis of stable plaque psoriasis for at least 6 months.
• Subjects must be in good health and free from any clinically significant disease, including but not limited to, conditions that may interfere with the evaluation of plaque psoriasis.

You may not qualify if…

• Female Subjects who are pregnant, nursing or planning to become pregnant during study participation.
• History of allergy or sensitivity to retinoid, corticosteroids and/or history of any drug hypersensitivity or intolerance which, in the opinion of the Investigator, would compromise the safety of the Subject or the results of the study.

Where it is running

• Catawba Research, LLC — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.